Zolmitriptan

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)0.95 [0.52, 1.74]27%2 studies56,790506not evaluable ROB-
Major congenital malformations1.86 [0.53, 6.51]-1 study11144not evaluable ROB-

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low birth weight (< 2500g)1.35 [0.53, 3.45]-1 study19156not evaluable ROB-
Preterm (< 37 weeks)0.96 [0.44, 2.08]-1 study28156not evaluable ROB-
Small for gestational age (weight)1.15 [0.50, 2.65]-1 study24156not evaluable ROB-

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Postpartum hemorrhage0.61 [0.13, 2.81]-1 study2917not evaluable ROB-

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Neonatal medical care3.89 [1.08, 13.95]-1 study1517not evaluable ROB7.24 [1.38; .]

Hide endpoints reported in only one study ...